When to use biological agents in inflammatory bowel disease

Article de revue

Avec comité de lecture

Crispin Corte, Payal Saxena, Stephen Tattersall, Christian Selinger et Rupert W Leong

Journal of gastroenterology and hepatology, Vol.27(7), pp.1141-1149

07/2012

PMID: 22188169

Résumé

biological agent

cell adhesion

Crohn's

cytokine

efficacy

inflammation

inflammatory bowel disease

safety

treatment

tumor necrosis factor

ulcerative colitis

1 Consultations de la notice

Titre: When to use biological agents in inflammatory bowel disease
Créateurs - sans rôle: Crispin Corte - Gastroenterology and Liver Services, Concord Hospital, Sydney Local Health District, Sydney, New South Wales, Australia
Payal Saxena - Gastroenterology and Liver Services, Concord Hospital, Sydney Local Health District, Sydney, New South Wales, Australia
Stephen Tattersall - Gastroenterology and Liver Services, Concord Hospital, Sydney Local Health District, Sydney, New South Wales, Australia
Christian Selinger - Gastroenterology and Liver Services, Concord Hospital, Sydney Local Health District, Sydney, New South Wales, Australia
Rupert W Leong - Gastroenterology and Liver Services, Concord Hospital, Sydney Local Health District, Sydney, New South Wales, Australia
Détails de publication: Journal of gastroenterology and hepatology, Vol.27(7), pp.1141-1149
Éditeur: Blackwell Publishing Asia
Nombre de pages: 9
Identifiants: 99159072309311
Unité académique: Maladies Infectieuses et Vecteurs : Ecologie, Génétique, Evolution et Contrôle - MIVEGEC
Langue: English
Type de ressource: Journal article